Malaria caused by P. falciparum poses a significant global health burden, particularly in sub-Saharan Africa. Current control measures, including insecticide-treated bed nets and antimalarial drugs, have limitations due to the development of drug resistance and insecticide resistance. A vaccine offers a promising complementary strategy to reduce the incidence and mortality of malaria.
